DMD Intelligence

Email Marketing Tips for a Successful 2016

Roger Korman, President

One of our most shared articles of the year was The Value-Add of Triggered Email in Digital Marketing. Recently, Jeanne Jennings wrote how email marketing automation is going to be a major component in email marketing programs for 2016. Her article, Setting the stage for a successful email marketing automation campaign was originally published on ClickZ.

Read More
Topics: Email Marketing, Pharma Marketing, Email Campaign Design & Deployment

Does A Click Really Represent Engagement?

Roger Korman, President

All too often, pharma marketers are woo'd by vanity metrics that don't offer the full story on marketing campaign performance. Is a "like" worth more than a share? A retweet more important than a mention? In a recent article on MediaPost, April Mullen writes about the value of a click and its relationship to other performance metrics. DMD published a similar article on email marketing metrics, Emerging Trends in Healthcare Marketing, in April 2015.

Read More
Topics: Email Marketing, Pharma Marketing, Email Campaign Design & Deployment, Precision Targeting

5 Reasons People Don’t Open Your Emails

Roger Korman, President

With the data that healthcare marketers have access to, there is no excuse for diminishing returns in the email channel. It is far too easy to perform A/B tests to determine which elements generate the most engagement. To set your 2016 up for success, we are sharing Tahir Akbar's article 5 Reasons People Don’t Open Your Emails, originally published on Business2Community.com.

Read More
Topics: Email Marketing, Pharma Marketing, Audience Identity Management

Pharma and the Digital Revolution

Roger Korman, President

In a recent article by McKinsey & Company, David Champagne, Amy Hung and Oliver Leclerc discuss how pharma companies are revamping their traditional business models to accomodate the ever-changing digital landscape. DMD published a similar blog in July 2015, The Digital Solution to Vacant Territories.

Read More
Topics: AIM, Pharma Marketing, Audience Identity Management

Your Exposure From An Invalidated Email List

Roger Korman, President

You might observe the aches and pains companies, like DMD, withstand in order to authenticate an email list and wonder why we go to all that trouble. After all, is it really the end of the world if you have some bad email addresses or a few non-healthcare-professional recipients? What's the worst that could happen? In reality, an unauthenticated email list exposes you to all sorts of risk and liability, both financially and legally.

Read More
Topics: Email Marketing, Pharma Marketing, Email List Quality, Precision Targeting, Physician Engagement

Keep Your Email Out of the Spam Folder

Roger Korman, President

Delivery rates don't necessarily capture everything that's going on in your email campaign. You can't assume that your target healthcare professional (HCP) sees or reads the message simply because it didn't bounce back. In fact, your HCP might not read any message sent to that email account. Did you know low mailbox usage rates have become a major detriment to email deliverability?

Read More
Topics: Email Marketing, Pharma Marketing, Email List Quality

The Top 6 Signs Your Email List Isn't Authenticated

Roger Korman, President

Imagine you wrote a book and wanted to send the manuscript to publishing houses. For reasons unknown, instead of looking online for recent contact information, you pick up a dated reference book with publishers' addresses. You first send your manuscript to a publisher that you later learn went out of business five years ago. You then send it to a company that left the publishing business a decade ago. You try once more, but this time, your book gets returned because the publisher has moved. Your book never gets published.

Read More
Topics: Email Marketing, Pharma Marketing, Email List Quality

Setting the Bar for Email Sourcing and List Authentication

Roger Korman, President

Email lists have something in common with racehorses and purebred dogs – where they come from matters. The data sources from which your email addresses are culled is generally known as your list pedigree. Your email list pedigree will directly affect the success of your email marketing campaign, from deliverability to ROI. If you purchased an unauthenticated email list from an unreliable source, you now know why your campaign is foundering. The solution is purchasing a list from a company that vets the addresses through reliable email sourcing practices. 

Read More
Topics: Email Marketing, Precision Targeting, Pharma Marketing, Email List Quality

Authenticated Lists Mean More Efficient Campaign Spending

Roger Korman, President

Think of a dartboard on a wall. To hit the bullseye, you would never throw darts at the entire wall and hope for the best. That's a waste of your darts, your time, and your energy. Instead, you would aim for the dartboard only – specifically, the bullseye.

Read More
Topics: Email Marketing, Pharma Marketing, Email List Quality

Subscribe to Email Updates

About the Blog

DMD President Roger Korman and his management team publish weekly articles on digital communication and technology in healthcare.

Articles are published that cover website visitor identity, the value of authenticated healthcare professional databases for use in multichannel marketing to physicians and healthcare professionals. DMD clients in pharma, hospital and health systems, agencies, and physician marketing companies rely on DMD's email and AIMSM technologies to improve communication with healthcare professionals across marketing channels.